Electrolytes supplementation can decrease the risk of nephrotoxicity in patients with solid tumors undergoing chemotherapy with cisplatin

Electrolytes supplementation can decrease the risk of nephrotoxicity in patients with solid tumors undergoing chemotherapy with cisplatin

Abstract Background Cisplatin is an important drug in the treatment of various Cancers. However, this drug causes nephrotoxicity that is linked to electrolyte derangement. The aim of this study was to evaluate the effect of electrolyte supplementation in reducing kidney injury in patients receiving...

Full description

Bibliographic Details
Main Authors: Omary M. S. Minzi, Tatu E. Lyimo, Francis F. Furia, Alphonce I. Marealle, Manase Kilonzi, George M. Bwire, Christina Malichewe
Format: Article
Language:English
Published: BMC 2020-09-01
Series:BMC Pharmacology and Toxicology
Subjects:
Triple electrolyte supplementation
Cancer
Cisplatin, nephrotoxicity
Serum creatinine, normal saline
Online Access:http://link.springer.com/article/10.1186/s40360-020-00448-9

Internet

http://link.springer.com/article/10.1186/s40360-020-00448-9

Similar Items